USPTO serial 79351124
IT PHARMA INNOVATING TECHNOLOGY PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 23, 2024
- Examiner
- PARKS, KIMBERLY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IT PHARMA INNOVATING TECHNOLOGY PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
ES
Other trademarks owned by INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
ES
Other trademarks owned by INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
ES
Other trademarks owned by INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jesus Sanchelima, Esq.
Jesus Sanchelima, Esq. Sanchelima & Associates, P.A.235 S.W. Le Jeune RoadMiami, FL 33134-1762United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics; non-medicinal toiletries; essential oils; non-medicinal hair lotions; cosmetic lotions for skin care; non-medicated essences for skin care; non-medicated preparations for skin care; beauty masks; body mask lotions for cosmetic use; skin care creams other than for medical use; tissues impregnated with cosmetic preparations; cosmetic preparations for slimming; cosmetic preparations for topical use; cosmetics for wrinkle treatment | ACTIVE | — |
| 005 | Sanitary preparations for medical use; medical products, namely, liquid pharmaceutical treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; leaflet pharmaceutical treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; medicated cosmetic solutions in ampoules for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; medicated cosmetic solutions in vials for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; pharmaceutical preparations and substances for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; sanitary preparations for medical purposes, and products thereof, namely, liquid treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; leaflet treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; antioxidant solution in spray being food supplements; chemical preparations for sanitary use; medicinal hair lotions; injectable pharmaceutical products for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; injectable sanitary preparations products for medical use; medicinal creams for skin care; medicinal lotions for skin care; pharmacological pharmaceutical preparations for skin care; medical and pharmaceutical preparations, for application by means of medical devices, namely, for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; pharmaceutical products for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; dietetic substances in the nature of liquid treatments, leaflet treatments, medicated cosmetic solutions in ampoules, medicated cosmetic solutions in vials, and antioxidant solution in spray for medical use; dietetic foods for medical use; food for babies; dietetic supplements for humans. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
- Other trademarks owned by INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
- Other trademarks owned by INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named IT PHARMA INNOVATING TECHNOLOGY PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 29, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 27, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 27, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 23, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 7, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 7, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 7, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 17, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 17, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 1, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 1, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 1, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 1, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 1, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 25, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 6, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 6, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 7, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 7, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 7, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 6, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 6, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |